Risk of death, thrombotic and hemorrhagic events in patients with atrial fibrillation and systemic autoimmune diseases

7 April 2024 (08:30 - 15:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Tommaso Bucci

University of Perugia, Perugia (Italy)

4 More presentations in this session

Presentation thumbnail

Associations of fat and muscle mass indices with incident atrial fibrillation: data of PREVEND

Doctor N. Suthahar (Rotterdam, NL)

Abstract Slides Video

Presentation thumbnail

Atrial high-rate episodes detected by cardiac implantable electronic devices: arrhythmic burden and progression towards de-novo clinical atrial fibrillation

Doctor J. Imberti (Modena, IT)

Abstract Slides Video

Presentation thumbnail

In-hospital mortality following catheter ablation procedures in Germany: insights from the VARY project

Doctor J. Vogler (Hamburg, DE)

Abstract Slides Video

Presentation thumbnail

The influence of subclavian ansae stimulation on cardiac hemodynamics and electrophysiology in atrial fibrillation- exploring a novel target for neuromodulation in atrial fibrillation (SAS-AF study)

Doctor V. Kanthasamy (London, GB)

Abstract Slides Video

Access the full session

Session thumbnail

Atrial fibrillation: diagnostic - clinical

The Event

Event poster

EHRA 2024

7 April - 9 April 2024

You may be interested in

Congress Presentation

Predictors of adverse cardiac events in a large cohort of patients with antiphospholipid syndrome

Congress Presentation

Non-alcoholic fatty liver disease in patients with atrial fibrillation: a report from a global federated health network.

Congress Presentation

Inflammation and long-term outcomes after first-time direct current cardioversion for atrial fibrillation: a nationwide register study

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources